Olympus (OCPNY) and Its Competitors Critical Survey

Olympus (OTCMKTS:OCPNY) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Olympus to related companies based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, valuation, risk and earnings.

Dividends

Olympus pays an annual dividend of $0.08 per share and has a dividend yield of 0.4%. Olympus pays out 9.8% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.5% of their earnings in the form of a dividend.

Profitability

This table compares Olympus and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Olympus	13.80%	24.30%	9.30%
Olympus Competitors	-303.57%	-175.14%	-22.20%

Valuation and Earnings

This table compares Olympus and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Olympus	$7.74 billion	$1.03 billion	21.95
Olympus Competitors	$1.87 billion	$136.27 million	5.88

Olympus has higher revenue and earnings than its rivals. Olympus is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of recent recommendations for Olympus and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Olympus	0	0	1	0	3.00
Olympus Competitors	4291	10580	18364	831	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.65%. Given Olympus’ rivals higher probable upside, analysts plainly believe Olympus has less favorable growth aspects than its rivals.

Volatility & Risk

Olympus has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Olympus’ rivals have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of Olympus shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Olympus beats its rivals on 9 of the 15 factors compared.

About Olympus

Olympus Corporation is a Japan-based medical technology company focused on developing and supplying equipment and services for medical procedures. Its products include gastrointestinal endoscopes and related systems, surgical endoscopes, and endotherapy devices used in diagnosis and treatment. The company’s roots date to 1919, when it was established in Japan as Takachiho Seisakusho to produce microscopes. Over time, Olympus became known for optical products, but it has since exited its camera and scientific solutions businesses to concentrate on medical technology.